Clinical Trial

The Akershus Study of Ischemic Stroke and Thrombolysis -1

Study acronym: ASIST-1
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 5, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This observational study comprises consecutively patients with cerebrovascular diseases admitted to the Stroke Unit at Akershus University Hospital in Norway. Akershus University Hospital is the largest emergency care hospital in Norway and has a catchment area covering a population of 550.000, which is approximately 10 % of the Norwegian population and reasonably representative according to data from Statistics Norway. The hospital is public and serving both as a primary hospital and a university hospital. Due to the Norwegian, national, all-covering health-insurance, all patients enter the hospital and are considered for further in-patient care on the same conditions. The hospital has a stroke unit classified as a comprehensive stroke center according to European Stroke Organisation standards. Acute stroke management follows national and international guidelines. Overall, the ASIST-1 study will investigate management, outcome and prognosis of stroke and stroke care pathways and later follow up in primary care using several approaches combining existing clinical data from a representative population with different Norwegian health registries. Parts of the study are retrospective with prospective follow-up by health registries and parts of the study are prospective.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-05-12; most recent amendment 2025-02-03.
Trial Details
NCT Number NCT05378490
Lead Sponsor University Hospital, Akershus
Collaborators: University of Oslo, Oslo University Hospital
Conditions Stroke, Acute, Intracerebral Hemorrhage, Stroke, Ischemic, TIA
Enrollment 6,000 participants
Start Date 2012-01-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2040-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-05